Global Prostate-Specific Antigen Testing Market Growth (Status and Outlook) 2025-2031

The global Prostate-Specific Antigen Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Prostate-Specific Antigen Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Prostate-Specific Antigen Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Prostate-Specific Antigen Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Prostate-Specific Antigen Testing players cover Xiamen Biotime Biotechnology Co., Ltd., HWTAi,, OptiBio Co., Ltd, Jiangsu MicroDiag Biomedicine Technology Co.,Ltd., Beijing Hotgen Biotechn Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Prostate-Specific Antigen Testing Industry Forecast” looks at past sales and reviews total world Prostate-Specific Antigen Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate-Specific Antigen Testing sales for 2025 through 2031. With Prostate-Specific Antigen Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate-Specific Antigen Testing industry.

This Insight Report provides a comprehensive analysis of the global Prostate-Specific Antigen Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostate-Specific Antigen Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate-Specific Antigen Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate-Specific Antigen Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate-Specific Antigen Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate-Specific Antigen Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

Immunoassay

Timely Test Kits

Segmentation by Application:

Hospital

Diagnostic Laboratory

Specialty Clinic

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Xiamen Biotime Biotechnology Co., Ltd.

HWTAi,

OptiBio Co., Ltd

Jiangsu MicroDiag Biomedicine Technology Co.,Ltd.

Beijing Hotgen Biotechn Co., Ltd

Humasis,AccuquikTMTest Kits

CTK Biotech, Inc.

INTEC

XIAMEN BOSON BIOTECH CO.,LTD

AccuBioTech Co, Ltd.

Bio-Rad Laboratories, Inc.

Accuquik Test Kits

OPKO Health, Inc.

bioMérieux SA

Beckman Coulter, Inc.

Abbott

Siemens Healthcare

DiaSorin

F.Hoffmann-La Roche Ltd

Mediwatch (LABORIE)

BodiTech

Bristol-Myers Squibb Company

GE Healthcare

Endocare

GlaxoSmithKline

Anixa Biosciences

Ortho Clinical

Fujirebio

Pharmacia Delfia

Please note: The report will take approximately 2 business days to prepare and deliver.